We're raising our price target on Cardinal Health after another stellar quarter of profits
The drug distributor also raised its full-year earnings guidance.
Investing
We're raising our price target on Cardinal Health after another stellar quarter of profits
National Trade News policy desk (2026-11-05): The drug distributor also raised its full-year earnings guidance. Primary source: original at CNBC Finance (cnbc.com).